USF1 modulates transcription and cellular functions by regulating multiple transcription factors in Huh7 cells

Zeng,Yan-Li; Zeng,Yan-Li; Gao,Fei; Gao,Fei; Zhang,Can; Zhang,Can; Ren,Pei-Pei; Ren,Pei-Pei; Ma,Li; Ma,Li; Wang,Xin; Wang,Xin; Wang,Ruzhen; Wang,Ruzhen; Kang,Yi; Kang,Yi; Li,Ke; Li,Ke

doi:10.3892/ol.2023.14119

USF1 modulates transcription and cellular functions by regulating multiple transcription factors in Huh7 cells

Authors:
- Yan-Li Zeng
- Fei Gao
- Can Zhang
- Pei-Pei Ren
- Li Ma
- Xin Wang
- Ruzhen Wang
- Yi Kang
- Ke Li
View Affiliations

Affiliations: Department of Infectious Diseases, Henan Key Laboratory for Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, P.R. China, Department of Infectious Diseases, Henan University, Zhengzhou, Henan 450003, P.R. China
Published online on: October 30, 2023 https://doi.org/10.3892/ol.2023.14119
Article Number: 532
Copyright: © Zeng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Liver cancer, including hepatocellular carcinoma (HCC), is a malignant tumor that has high rates of metastasis and mortality worldwide. Upstream transcription factor 1 (USF1) is a canonical transcription factor (TF) and is associated with the pathogenesis of several cancers, but its biological functions and molecular targets in HCC remain unclear. Huh7 cells that overexpress USF1 were used with whole transcriptome profiling through RNA sequencing and chromatin immunoprecipitation (ChIP) sequencing methods to investigate the downstream targets of USF1. Reverse transcription‑quantitative PCR was then used to validate the downstream targets. The results showed that USF1 significantly regulates 350 differentially expressed genes (DEGs). The upregulated DEGs were primarily protein‑coding genes enriched in immune and inflammation response pathways, while the downregulated DEGs were mainly coding long non‑coding (lnc)RNAs, indicating the regulatory function of USF1. It was also demonstrated that USF1 directly binds to the promoter region of 2,492 genes, which may be involved in the viral progression and cell proliferation pathways. By integrating these two datasets, 16 overlapped genes were detected, including downregulated lncRNA‑NEAT1 and upregulated TF‑ETV5. The downregulated lncRNA‑NEAT1 showed reverse expression pattern and prognosis result compared with that of USF1 in patients with liver cancer, while upregulated TF‑ETV5 showed consistent results with USF1. Promoter region motif analysis indicated that ETV5 has more binding motifs and genes than USF1 itself for USF1‑regulated DEGs, indicating that USF1 may indirectly modulate gene expression by regulating ETV5 expression in Huh7 cells. The study also validated the direct interaction between USF1 and the promoter of ETV5 using ChIP‑qPCR. In summary, the results demonstrated that USF1 binds to the promoter region of thousands of genes and affects a large part of DEGs indirectly. Downstream genes, including lncRNA‑NEAT1 and TF‑ETV5, may also have potential functions in the regulated network by USF1 and have potential functions in the progression of HCC. The present findings suggested that USF1 and its downstream targets could be potential targets for HCC therapy in the future.

View Figures

View References

1	Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
2	Cao W, Chen HD, Yu YW, Li N and Chen WQ: Changing profiles of cancer burden worldwide and in China: A secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 134:783–791. 2021. View Article : Google Scholar : PubMed/NCBI
3	Anwanwan D, Singh SK, Singh S, Saikam V and Singh R: Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 1873:1883142020. View Article : Google Scholar : PubMed/NCBI
4	Nakagawa H, Fujita M and Fujimoto A: Genome sequencing analysis of liver cancer for precision medicine. Semin Cancer Biol. 55:120–127. 2019. View Article : Google Scholar : PubMed/NCBI
5	Rada-Iglesias A, Ameur A, Kapranov P, Enroth S, Komorowski J, Gingeras TR and Wadelius C: Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. Genome Res. 18:380–392. 2008. View Article : Google Scholar : PubMed/NCBI
6	Lu TC, Wang Z, Feng X, Chuang P, Fang W, Chen Y, Neves S, Maayan A, Xiong H, Liu Y, et al: Retinoic acid utilizes CREB and USF1 in a transcriptional feed-forward loop in order to stimulate MKP1 expression in human immunodeficiency virus-infected podocytes. Mol Cell Biol. 28:5785–5794. 2008. View Article : Google Scholar : PubMed/NCBI
7	Zeng Y, Li H, Zhang X, Shang J and Kang Y: Basal transcription of APOBEC3G is regulated by USF1 gene in hepatocyte. Biochem Biophys Res Commun. 470:54–60. 2016. View Article : Google Scholar : PubMed/NCBI
8	Kim KC, Yun J, Son DJ, Kim JY, Jung JK, Choi JS, Kim YR, Song JK, Kim SY, Kang SK, et al: Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1. Theranostics. 8:4409–4428. 2018. View Article : Google Scholar : PubMed/NCBI
9	Chang JTC, Yang HT, Wang TCV and Cheng AJ: Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells. Mol Carcinog. 44:183–192. 2005. View Article : Google Scholar : PubMed/NCBI
10	Costa L, Corre S, Michel V, Le Luel K, Fernandes J, Ziveri J, Jouvion G, Danckaert A, Mouchet N, Da Silva Barreira D, et al: USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis. Gut. 69:1582–1591. 2020. View Article : Google Scholar : PubMed/NCBI
11	Song X, Zhu M, Li H, Liu B, Yan Z, Wang W, Li H, Sun J and Li S: USF1 promotes the development of knee osteoarthritis by activating the NF-κB signaling pathway. Exp Ther Med. 16:3518–3524. 2018.PubMed/NCBI
12	Zhang L, Handel MV, Schartner JM, Hagar A, Allen G, Curet M and Badie B: Regulation of IL-10 expression by upstream stimulating factor (USF-1) in glioma-associated microglia. J Neuroimmunol. 184:188–197. 2007. View Article : Google Scholar : PubMed/NCBI
13	Wei G, Zhang T, Li Z, Yu N, Xue X, Zhou D, Chen Y, Zhang L, Yao X and Ji G: USF1-mediated upregulation of lncRNA GAS6-AS2 facilitates osteosarcoma progression through miR-934/BCAT1 axis. Aging (Albany NY). 12:6172–6190. 2020. View Article : Google Scholar : PubMed/NCBI
14	Sun Q, Li J, Li F, Li H, Bei S, Zhang X and Feng L: LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p/USF1 pathway. Cell Prolif. 52:e126872019. View Article : Google Scholar : PubMed/NCBI
15	Zhao X and Wang T, Liu B, Wu Z, Yu S and Wang T: Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: A case-control study. Tumour Biol. 36:2551–2558. 2015. View Article : Google Scholar : PubMed/NCBI
16	Liu S, Qiu J, He W, Geng C, He G, Liu C, Cai D, Liu X, Tian B and Pan H: TUG1 long non-coding RNA enlists the USF1 transcription factor to overexpress ROMO1 leading to hepatocellular carcinoma growth and metastasis. MedComm (2020). 1:386–399. 2020.PubMed/NCBI
17	Peng JY, Cai DK, Zeng RL, Zhang CY, Li GC, Chen SF, Yuan XQ and Peng L: Upregulation of superenhancer-driven LncRNA FASRL by USF1 promotes de novo fatty acid biosynthesis to exacerbate hepatocellular carcinoma. Adv Sci (Weinh). 10:e22047112022.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
18	Chen B, Chen XP, Wu MS, Cui W and Zhong M: Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma. Eur J Med Res. 19:452014. View Article : Google Scholar : PubMed/NCBI
19	Kim D, Langmead B and Salzberg SL: HISAT: A fast spliced aligner with low memory requirements. Nat Methods. 12:357–360. 2015. View Article : Google Scholar : PubMed/NCBI
20	Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ and Pachter L: Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 28:511–515. 2010. View Article : Google Scholar : PubMed/NCBI
21	Robinson MD, McCarthy DJ and Smyth GK: edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26:139–140. 2010. View Article : Google Scholar : PubMed/NCBI
22	Langmead B and Salzberg SL: Fast gapped-read alignment with bowtie 2. Nat Methods. 9:357–359. 2012. View Article : Google Scholar : PubMed/NCBI
23	Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W and Liu XS: Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9:R1372008. View Article : Google Scholar : PubMed/NCBI
24	Ramírez F, Ryan DP, Grüning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S, Dündar F and Manke T: deepTools2: A next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44((W1)): W160–W165. 2016. View Article : Google Scholar : PubMed/NCBI
25	Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H and Glass CK: Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 38:576–589. 2010. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
27	Tang Z, Kang B, Li C, Chen T and Zhang Z: GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47((W1)): W556–W560. 2019. View Article : Google Scholar : PubMed/NCBI
28	Nagy Á, Munkácsy G and Győrffy B: Pancancer survival analysis of cancer hallmark genes. Sci Rep. 11:60472021. View Article : Google Scholar : PubMed/NCBI
29	Corre S and Galibert MD: Upstream stimulating factors: Highly versatile stress-responsive transcription factors. Pigment Cell Res. 18:337–348. 2005. View Article : Google Scholar : PubMed/NCBI
30	Dong P, Xiong Y, Yue J, Hanley SJB, Kobayashi N, Todo Y and Watari H: Long non-coding RNA NEAT1: A novel target for diagnosis and therapy in human tumors. Front Genet. 9:4712018. View Article : Google Scholar : PubMed/NCBI
31	Tiruppathi C, Soni D, Wang DM, Xue J, Singh V, Thippegowda PB, Cheppudira BP, Mishra RK, Debroy A, Qian Z, et al: The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation. Nat Immunol. 15:239–247. 2014. View Article : Google Scholar : PubMed/NCBI
32	Cho MJ, Lee DG, Lee JW, Hwang B, Yoon SJ, Lee SJ, Park YJ, Park SH, Lee HG, Kim YH, et al: Endothelial PTP4A1 mitigates vascular inflammation via USF1/A20 axis-mediated NF-κB inactivation. Cardiovasc Res. 119:1265–1278. 2023. View Article : Google Scholar : PubMed/NCBI
33	Yu LX, Ling Y and Wang HY: Role of nonresolving inflammation in hepatocellular carcinoma development and progression. NPJ Precis Oncol. 2:62018. View Article : Google Scholar : PubMed/NCBI
34	Liu JKH, Irvine AF, Jones RL and Samson A: Immunotherapies for hepatocellular carcinoma. Cancer Med. 11:571–591. 2022. View Article : Google Scholar : PubMed/NCBI
35	Dahlquist KJV, Voth LC, Fee AJ and Stoeckman AK: An autocrine role for CXCL1 in progression of hepatocellular carcinoma. Anticancer Res. 40:6075–6081. 2020. View Article : Google Scholar : PubMed/NCBI
36	Xu J, Lin H, Wu G, Zhu M and Li M: IL-6/STAT3 is a promising therapeutic target for hepatocellular carcinoma. Front Oncol. 11:7609712021. View Article : Google Scholar : PubMed/NCBI
37	Zhang L, Zhang L, Li H, Ge C, Zhao F, Tian H, Chen T, Jiang G, Xie H, Cui Y, et al: CXCL3 contributes to CD133(+) CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation. Sci Rep. 6:274262016. View Article : Google Scholar : PubMed/NCBI
38	Ringelhan M, McKeating JA and Protzer U: Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci. 372:201602742017. View Article : Google Scholar : PubMed/NCBI
39	Deng C, Li Y, Liang S, Cui K, Salz T, Yang H, Tang Z, Gallagher PG, Qiu Y, Roeder R, et al: USF1 and hSET1A mediated epigenetic modifications regulate lineage differentiation and HoxB4 transcription. PLoS Genet. 9:e10035242013. View Article : Google Scholar : PubMed/NCBI
40	Guo J, Fang W, Chen X, Lin Y, Hu G, Wei J, Zhang X, Yang C and Li J: Upstream stimulating factor 1 suppresses autophagy and hepatic lipid droplet catabolism by activating mTOR. FEBS Lett. 592:2725–2738. 2018. View Article : Google Scholar : PubMed/NCBI
41	Kang K, Choi Y, Moon H, You C, Seo M, Kwon G, Yun J, Beck B and Kang K: Epigenomic analysis of RAD51 ChIP-seq data reveals cis-regulatory elements associated with autophagy in cancer cell lines. Cancers (Basel). 13:25472021. View Article : Google Scholar : PubMed/NCBI
42	Oh S, Shin S and Janknecht R: ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors. Biochim Biophys Acta. 1826:1–12. 2012.PubMed/NCBI
43	Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, et al: Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res. 68:73–80. 2008. View Article : Google Scholar : PubMed/NCBI
44	Mao Z, Feng M, Li Z, Zhou M, Xu L, Pan K, Wang S, Su W and Zhang W: ETV5 regulates hepatic fatty acid metabolism through PPAR signaling pathway. Diabetes. 70:214–226. 2021. View Article : Google Scholar : PubMed/NCBI